Dulpatatug is a monoclonal antibody targeting ERBB2, which can be used for research on gastric cancer, breast cancer and non-small cell lung cancer.
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025.
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025.
















